Literature DB >> 21523925

Manual lymph drainage improving upper extremity edema and hand function in patients with systemic sclerosis in edematous phase.

Susanna Maddali Bongi1, Angela Del Rosso, Mauro Passalacqua, Sara Miccio, Marco Matucci Cerinic.   

Abstract

OBJECTIVE: In systemic sclerosis (SSc; scleroderma) patients in edematous phase, hand edema is often present. Manual lymph drainage (MLD) stimulates the lymphatic system and reduces edema. Our aim was to evaluate the efficacy of MLD in reducing edema and in improving functionality of the hands and perceived quality of life (QOL) in SSc patients in edematous phase.
METHODS: Of 35 SSc patients with edematous hands, 20 were treated with MLD according to the Vodder technique once a week for 5 weeks (intervention group), and 15 served as the observation group. Patients were evaluated at enrollment, at the end of treatment (T1), and after 9 weeks of followup (T2) by volumetric test (assessing hand volume), the Hand Mobility in Scleroderma (HAMIS) test, and 4 visual analog scales (VAS; scored 0-10) evaluating the perception of hand edema and pain and their interference on daily activities. QOL and disability were assessed by the physical synthetic index (PSI) and mental synthetic index (MSI) of the Short Form 36 (SF-36) and by the Health Assessment Questionnaire (HAQ).
RESULTS: In the intervention group, hand volume, the HAMIS test, and the 4 VAS were improved significantly at the end of treatment (P < 0.001). The results were maintained at T2 (P < 0.001). The HAQ and the PSI and MSI of the SF-36 also improved significantly at T1 (P < 0.001), but only PSI improvement was maintained at T2 (P < 0.001). In the observation group, no improvement at T1 and at T2 was observed.
CONCLUSION: In SSc, MLD significantly reduces hand edema and improves hand function and perceived QOL.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2011        PMID: 21523925     DOI: 10.1002/acr.20487

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  16 in total

Review 1.  [Therapeutic management in early disease stages of systemic sclerosis : early diagnosis - early symptoms - early problems].

Authors:  M Frerix; F M P Meier; W Hermann; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2013-12       Impact factor: 1.372

2.  [Persistent reddening and induration after wound cleansing with octenidine].

Authors:  M Seegräber; A Wollenberg
Journal:  Hautarzt       Date:  2017-04       Impact factor: 0.751

3.  Hand Impairment in Systemic Sclerosis: Various Manifestations and Currently Available Treatment.

Authors:  Amber Young; Rajaie Namas; Carole Dodge; Dinesh Khanna
Journal:  Curr Treatm Opt Rheumatol       Date:  2016-07-19

4.  French recommendations for the management of systemic sclerosis.

Authors:  Eric Hachulla; Christian Agard; Yannick Allanore; Jerome Avouac; Brigitte Bader-Meunier; Alexandre Belot; Alice Berezne; Anne-Sophie Bouthors; Geraldine Condette-Wojtasik; Joël Constans; Pascal De Groote; Elisabeth Diot; Florence Dumas; Patrick Jego; Francisca Joly; David Launay; Veronique Le Guern; Janine-Sophie Le Quintrec; Geraldine Lescaille; Christophe Meune; Bruno Moulin; Christelle Nguyen; Nadine Omeish; Frederic Pene; Marie-Aleth Richard; Juliette Rochefort; Alexandra Roren; Olivier Sitbon; Vincent Sobanski; Marie-Elise Truchetet; Luc Mouthon
Journal:  Orphanet J Rare Dis       Date:  2021-07-26       Impact factor: 4.123

5.  TNFA -308G>A and -238G>A polymorphisms and risk to systemic sclerosis: impact on TNF-α serum levels, TNFA mRNA expression, and autoantibodies.

Authors:  José Alvaro Lomelí-Nieto; José Francisco Muñoz-Valle; Christian Johana Baños-Hernández; José Eduardo Navarro-Zarza; María Guadalupe Ramírez-Dueñas; Pedro Ernesto Sánchez-Hernández; Andrea Carolina Machado-Sulbaran; Isela Parra-Rojas; Mariel García-Chagollán; Jorge Hernández-Bello
Journal:  Clin Exp Med       Date:  2019-07-29       Impact factor: 3.984

Review 6.  Clinical significance and usefulness of rehabilitation for systemic sclerosis.

Authors:  Naoki Mugii; Yasuhito Hamaguchi; Susanna Maddali-Bongi
Journal:  J Scleroderma Relat Disord       Date:  2018-04-04

7.  Lymphedema secondary to limited cutaneous systemic sclerosis.

Authors:  Sónia Moreira; Jorge Crespo; Lèlita Santos
Journal:  BMJ Case Rep       Date:  2018-06-15

8.  Occupational Therapy Treatment to Improve Upper Extremity Function in Individuals with Early Systemic Sclerosis: A Pilot Study.

Authors:  Susan L Murphy; Mary Whitehouse Barber; Kate Homer; Carole Dodge; Gary R Cutter; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-11       Impact factor: 4.794

9.  Intensive and app-delivered occupational therapy to improve upper extremity function in early diffuse cutaneous systemic sclerosis: a pilot two-arm trial.

Authors:  Susan L Murphy; Mary Barber; Suiyuan Huang; Maya Sabbagh; Gary Cutter; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2021-11-03       Impact factor: 7.580

10.  Rehabilitation Interventions in Systemic Sclerosis: A Systematic Review and Future Directions.

Authors:  Susan L Murphy; Janet L Poole; Yen T Chen; Alain Lescoat; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-12-22       Impact factor: 5.178

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.